News

Blog

Monthly Giving Program

In 2021, we received over $20,000.00 from 28 donors in NETRF’s Monthly Giving Program! This is an excellent way for donors who want to stay connected to a loved one’s memory, or for those who want to make a larger donation and pay it over time.

Read More »
Blog

Grant Opportunities Announcement

Submit Letters of Intent by March 7, 2022  The Neuroendocrine Tumor Research Foundation (NETRF), Boston,  Massachusetts, has released its 2022 Request for Applications.  We invite

Read More »
Blog

The 2021 Virtual NET Research Symposium – Summary/Recap

The fourteenth annual NETRF Research Symposium successfully concluded last month with over 300 registered virtual attendees participating from around the globe for the second year in a row. The meeting included nearly 60 talks and posters representing the cutting edge of NET research where investigators reported their latest data and discoveries to share and discuss with colleagues. This year posters were available for viewing over the three days preceding the two-day meeting, resulting in over 300 poster views and ample time for discussions. Over 95% of registrants attended the two-days of talks and live discussions while the recorded talks and posters were viewed by over 100 more attendees over the following week.

Read More »
Blog

NETRF Announces Changes to its Board of Scientific Advisors

Dr. Thirlwell, the Mireille Gillings Professor of Cancer Genomics at the University of Exeter Medical School will assume the role in January of 2022. She is internationally renowned for advancing NET research, the clinical management of NETs and the integrated genomic analysis of cancer.

Read More »
Blog

Research Spotlight: Rodney Hicks, MD

Peptide receptor radionuclide therapy, or PRRT, has been available as a treatment option for some forms of neuroendocrine tumors – particularly for those NETs expressing the somatostatin receptor-2 (SSTR2) protein.

Read More »